Can we predict how severe asthma reshapes the lungs?
NCT ID NCT01716494
The trial has finished. Results may not be published yet.
First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time
Summary
This study follows children and adults with severe asthma over three years to see how their airways change and how lung function declines. Using advanced imaging and breathing tests, researchers aim to understand the process of airway remodeling and what makes some patients worsen faster. The findings could help identify early warning signs and guide future treatments to protect lung health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could reveal how severe asthma changes the airways over time, pointing toward new ways to predict or slow that damage.
- What could go wrong
- This is an observational study, not a treatment test, so it won't directly produce a new therapy. Results may take years and might not apply to all asthma patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
121 people
The number who actually took part.
- Started
-
Oct 2012
- Finished
-
Mar 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Subjects with asthma (severe asthma, well controlled asthma) and healthy normal controls from St. Louis region
- Ages
-
6 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Physician diagnosis of asthma, 2. Age 6 years and older 3. Evidence of historical reversibility, including either: 1. FEV1 bronchodilator reversibility ≥ 12%, or 2. Airway hyperresponsiveness reflected by a methacholine PC20 ≤16 mg/mL. Exclusion Criteria: 1. No primary medical caregiver, 2. Pregnancy (if undergoing methacholine challenge or bronchoscopy), 3. Current smoking 4. Smoking history \> 10 pack years if ≥ 30 years of age or smoking history \> 5 pack years if \< 30 years of age (Note: If a subject has a smoking history, no smoking within the past year) 5. Other chronic pulmonary disorders associated with asthma-like symptoms,including (but not limited to) cystic fibrosis, chronic obstructive pulmonary disease, chronic bronchitis, vocal cord dysfunction that is the sole cause of asthma symptoms, severe scoliosis or chest wall deformities that affect lung function, or congenital disorders of the lungs or airways, 6. History of premature birth before 35 weeks gestation, 7. Evidence that the participant or family may be unreliable or poorly adherent to their asthma treatment or study procedures, 8. Planning to relocate from the clinical center area before study completion, or 9. Any other criteria that place the subject at unnecessary risk according to the judgment of the Principal Investigator and/or attending physician(s) of record.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Climate-Friendly inhaler propellant match the old One's safety?
- Can a new drug curb asthma attacks when standard care falls short?
- Can a City-Wide asthma registry unlock new discoveries?
- Can a new shot tame severe asthma attacks?
- Could simple breathing exercises be a new weapon against COPD and asthma?
- Can tracking severe asthma over time unlock better treatments?